Who owns PYXIS ONCOLOGY INC?
- Ticker: PYXS
- CUSIP Number: 747324101
Tip: Access positions for across all investors
Analyze quarterly positions in Pyxis Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pyxis Oncology stock
Who bought or sold PYXIS ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deep Track Capital | 4.2M | $18M | 100% | Mar 2024 |
|
| Laurion Capital Management | 3.9M | $16M | 22% | Mar 2024 |
|
| Balyasny Asset Management | 2.6M | $11M | 100% | Mar 2024 |
|
| Ikarian Capital | 1.7M | $7.1M | 100% | Mar 2024 |
|
| Vanguard Group | 1.4M | $6.0M | 7% | Mar 2024 |
|
| Standard Life Aberdeen | 708k | $3.0M | 0% | Mar 2024 |
|
| Millennium Management | 657k | $2.8M | 4853% | Mar 2024 |
|
| Superstring Capital Management | 494k | $2.1M | 100% | Mar 2024 |
|
| Boothbay Fund Management | 493k | $2.1M | 100% | Mar 2024 |
|
| Monashee Investment Management | 443k | $1.9M | 100% | Mar 2024 |
|
| Hillhouse Capital Advisors | 383k | $1.6M | 0% | Mar 2024 |
|
| Geode Capital Management | 340k | $1.4M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 337k | $1.4M | 100% | Mar 2024 |
|
| Decheng Capital | 327k | $1.4M | 0% | Mar 2024 |
|
| BlackRock | 322k | $1.4M | 100% | Mar 2024 |
|
| Bank of New York Mellon | 312k | $1.0M | 92% | Jun 2024 |
|
| Bridgeway Capital Management | 232k | $986k | 100% | Mar 2024 |
|
| Jane Street | 175k | $747k | 1067% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 165k | $703k | 32% | Mar 2024 |
|
| Qube Research & Technologies | 153k | $652k | 100% | Mar 2024 |
|
| Renaissance Technologies | 148k | $630k | -59% | Mar 2024 |
|
| Man Group | 147k | $627k | 100% | Mar 2024 |
|
| Hrt Financial | 139k | $592k | 100% | Mar 2024 |
|
| Marshall Wace | 134k | $569k | 100% | Mar 2024 |
|
| State Street Corporation | 109k | $466k | 32% | Mar 2024 |
|
| Susquehanna International | 104k | $445k | 100% | Mar 2024 |
|
| Dimensional Fund Advisors | 102k | $434k | 0% | Mar 2024 |
|
| ExodusPoint Capital Management | 90k | $381k | 100% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 82k | $351k | 100% | Mar 2024 |
|
| CornerCap Investment Counsel | 75k | $319k | 0% | Mar 2024 |
|
| Yu Fan | 69k | $295k | 0% | Mar 2024 |
|
| Squarepoint Ops | 68k | $291k | 100% | Mar 2024 |
|
| XTX Topco | 66k | $281k | 100% | Mar 2024 |
|
| Cable Car Capital | 62k | $262k | 0% | Mar 2024 |
|
| Northern Trust | 61k | $261k | 100% | Mar 2024 |
|
| Marathon Trading Investment Management | 57k | $243k | 100% | Mar 2024 |
|
| Pier 88 Investment Partners | 51k | $219k | 100% | Mar 2024 |
|
| University Of Chicago | 49k | $161k | 0% | Jun 2024 |
|
| Citigroup | 45k | $190k | 100% | Mar 2024 |
|
| Morgan Stanley | 44k | $185k | 100% | Mar 2024 |
|
| Simplex Trading | 41k | $134k | 100% | Jun 2024 |
|
| Jump Financial | 41k | $172k | 100% | Mar 2024 |
|
| American Century Companies | 37k | $159k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 36k | $153k | 100% | Mar 2024 |
|
| Citadel Advisors | 30k | $130k | -72% | Mar 2024 |
|
| Commonwealth Equity Services | 30k | $129k | 134% | Mar 2024 |
|
| Point72 Asia | 30k | $127k | 100% | Mar 2024 |
|
| Bank of America Corporation | 30k | $127k | 50% | Mar 2024 |
|
| Cetera Investment Advisers | 29k | $125k | 100% | Mar 2024 |
|
| UBS Group | 28k | $120k | 856% | Mar 2024 |
|
| Y-Intercept | 28k | $120k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 26k | $109k | 2586% | Mar 2024 |
|
| Schulhoff & Company | 22k | $94k | 0% | Mar 2024 |
|
| NEOS Investment Management | 16k | $69k | 100% | Mar 2024 |
|
| Two Sigma Advisers | 16k | $67k | -76% | Mar 2024 |
|
| Charles Schwab Investment Management | 15k | $62k | 100% | Mar 2024 |
|
| Fullcircle Wealth | 12k | $45k | 100% | Jun 2024 |
|
| OMERS Administration Corporation | 12k | $50k | 100% | Mar 2024 |
|
| William Blair $ Company | 10k | $43k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 10k | $43k | 100% | Mar 2024 |
|
| Tower Research Capital | 9.7k | $41k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 3.1k | $13k | 18% | Mar 2024 |
|
| Macquarie Group | 1.1k | $5.008500 | 100% | Mar 2024 |
|
| Wells Fargo & Company | 834.00 | $3.6k | -67% | Mar 2024 |
|
| Harbour Investments | 581.00 | $2.5k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 500.00 | $2.1k | 0% | Mar 2024 |
|
| Goss Wealth Management | 250.00 | $1.1k | 100% | Mar 2024 |
|
| Coston, McIsaac & Partners | 30.00 | $0 | 0% | Mar 2024 |
|
| West Branch Capital | 25.00 | $107.000000 | 0% | Mar 2024 |
|
| FMR | 1.00 | $4.000000 | 100% | Mar 2024 |
|
Who sold out of Pyxis Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Harvest Investment Services | Dec 2023 | 112k | $202k |
| Two Sigma Investments | Dec 2023 | 92k | $165k |
| SG Americas Securities | Mar 2024 | 14k | $59k |
| Bleakley Financial Group | Dec 2023 | 11k | $20k |
| Kingsview Wealth Management | Dec 2023 | 11k | $19k |
| Hanson McClain Advisors | Mar 2024 | 200.00 | $852.000000 |